We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Thin Skin Adhesive Absorbs Wound Exudates

By HospiMedica International staff writers
Posted on 02 Mar 2014
A range of new skin wound dressings with properties similar to an acrylic adhesive form a gel when absorbing wound exudates.

The BeneHold range of absorbent wound dressings are designed to manage lightly to moderately exuding chronic and acute wounds, and are constructed of a self-adherent wound contact layer that turns into a soft gel that protects against wound dehydration and facilitates granulation, autolysis, and epithelization. More...
A smooth, water-resistant polyurethane top film acts as a barrier to external contaminants and bacteria. The dressings are also transparent, allowing for site visibility up to seven days.

The BeneHold range includes the Thin Absorbent Wound Dressing, the Standard Hydrocolloid Dressing, the Bordered Hydrocolloid Dressing with Odor Control, and the Bordered Sacral Hydrocolloid Dressing with Odor Control. All dressings exhibit superior fluid handling capacity, yet are thin and conformable to enhance patient comfort. The dressings are based on proprietary thin absorbent akin adhesive (TASA) technology; at only 0.1mm in thickness, TASA has the capacity to manage fluid in excess of traditional thin hydrocolloids. 

Other feature include high fluid handling capacity to maintain a moist wound environment through a high water vapor transmission rate and static absorption, minimizing skin maceration; low profile rounded corners to help prevent edge lift; and odor control via organic, noncytotoxic cyclodextrins that capture odor molecules. The BeneHold range are products of Vancive Medical Technologies (Chicago, IL, USA), a part of Avery Dennison (Glendale, CA, USA).

Related Links:

Vancive Medical Technologies
Avery Dennison
 


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.